S100A9 and myocardial infarction: These data support customized therapeutic strategies for short-term anti-S100A9 blockade during the early inflammatory phase post-MI, while long-term blockade affects the recovery of cardiac function during the reparatory phase; therefore, it is necessary to determine an appropriate therapeutic window.